Lobelin (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lobelin" in Serbian language version.

refsWebsite

Global rank Serbian rank

7nih.gov

4^th place

8^th place

6doi.org

2^nd place

4^th place

3semanticscholar.org

11^th place

23^rd place

2archive.org

6^th place

5^th place

archive.org

Marlow, S. P.; Stoller, J. K. (2003). „Smoking cessation”. Respiratory Care. 48 (12): 1238—54; discussion 1254—6. PMID 14651764.
Eyerman, D. J.; Yamamoto, B. K. (2005). „Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. The Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160—169. PMID 15331654. S2CID 19787823. doi:10.1124/jpet.104.072264.

doi.org

Stead LF, Hughes JR (2012). „Lobeline for smoking cessation”. Cochrane Database Syst Rev. 2012 (2): CD000124. PMC 7043274 . PMID 22336780. doi:10.1002/14651858.CD000124.pub2.
Buchhalter, A. R.; Fant, R. V.; Henningfield, J. E. (2008). „Novel pharmacological approaches for treating tobacco dependence and withdrawal: Current status”. Drugs. 68 (8): 1067—1088. PMID 18484799. S2CID 46875770. doi:10.2165/00003495-200868080-00005.
Neugebauer, Nichole M.; Harrod, Steven B.; Stairs, Dustin J.; Crooks, Peter A.; Dwoskin, Linda P.; Bardo, Michael T. (2007). „Lobelane decreases methamphetamine self-administration in rats”. European Journal of Pharmacology. 571 (1): 33—38. PMC 2104779 . PMID 17612524. doi:10.1016/j.ejphar.2007.06.003.
Eyerman, D. J.; Yamamoto, B. K. (2005). „Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. The Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160—169. PMID 15331654. S2CID 19787823. doi:10.1124/jpet.104.072264.
Polston, J. E.; Cunningham, C. S.; Rodvelt, K. R.; Miller, D. K. (2006). „Lobeline augments and inhibits cocaine-induced hyperactivity in rats”. Life Sciences. 79 (10): 981—990. PMID 16765386. doi:10.1016/j.lfs.2006.05.006.
Farook, J. M.; Lewis, B.; Gaddis, J. G.; Littleton, J. M.; Barron, S. (2009). „Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice”. Physiology & Behavior. 97 (3–4): 503—506. PMID 19268674. S2CID 23762679. doi:10.1016/j.physbeh.2009.02.031.

nih.gov

ncbi.nlm.nih.gov

Stead LF, Hughes JR (2012). „Lobeline for smoking cessation”. Cochrane Database Syst Rev. 2012 (2): CD000124. PMC 7043274 . PMID 22336780. doi:10.1002/14651858.CD000124.pub2.
Marlow, S. P.; Stoller, J. K. (2003). „Smoking cessation”. Respiratory Care. 48 (12): 1238—54; discussion 1254—6. PMID 14651764.
Buchhalter, A. R.; Fant, R. V.; Henningfield, J. E. (2008). „Novel pharmacological approaches for treating tobacco dependence and withdrawal: Current status”. Drugs. 68 (8): 1067—1088. PMID 18484799. S2CID 46875770. doi:10.2165/00003495-200868080-00005.
Neugebauer, Nichole M.; Harrod, Steven B.; Stairs, Dustin J.; Crooks, Peter A.; Dwoskin, Linda P.; Bardo, Michael T. (2007). „Lobelane decreases methamphetamine self-administration in rats”. European Journal of Pharmacology. 571 (1): 33—38. PMC 2104779 . PMID 17612524. doi:10.1016/j.ejphar.2007.06.003.
Eyerman, D. J.; Yamamoto, B. K. (2005). „Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. The Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160—169. PMID 15331654. S2CID 19787823. doi:10.1124/jpet.104.072264.
Polston, J. E.; Cunningham, C. S.; Rodvelt, K. R.; Miller, D. K. (2006). „Lobeline augments and inhibits cocaine-induced hyperactivity in rats”. Life Sciences. 79 (10): 981—990. PMID 16765386. doi:10.1016/j.lfs.2006.05.006.
Farook, J. M.; Lewis, B.; Gaddis, J. G.; Littleton, J. M.; Barron, S. (2009). „Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice”. Physiology & Behavior. 97 (3–4): 503—506. PMID 19268674. S2CID 23762679. doi:10.1016/j.physbeh.2009.02.031.

semanticscholar.org

api.semanticscholar.org

Buchhalter, A. R.; Fant, R. V.; Henningfield, J. E. (2008). „Novel pharmacological approaches for treating tobacco dependence and withdrawal: Current status”. Drugs. 68 (8): 1067—1088. PMID 18484799. S2CID 46875770. doi:10.2165/00003495-200868080-00005.
Eyerman, D. J.; Yamamoto, B. K. (2005). „Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum”. The Journal of Pharmacology and Experimental Therapeutics. 312 (1): 160—169. PMID 15331654. S2CID 19787823. doi:10.1124/jpet.104.072264.
Farook, J. M.; Lewis, B.; Gaddis, J. G.; Littleton, J. M.; Barron, S. (2009). „Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice”. Physiology & Behavior. 97 (3–4): 503—506. PMID 19268674. S2CID 23762679. doi:10.1016/j.physbeh.2009.02.031.